PolyCore Therapeutics, Inc. — Form D

PolyCore Therapeutics, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-17. The offering totals $4.7M, of which $4.7M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2022-03-17
• Form: D
• Accession: 0001567619-22-007140
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $4.7M
• Amount sold: $4.7M
• Investors: 5
• Date of first sale: 2022-02-11
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-437808

Issuer

• Name: PolyCore Therapeutics, Inc.
• CIK: 0001914733
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 3180 CHESTNUT STREET, SUITE 104, PHILADELPHIA, PA, 19104
• Phone: 484-888-2661

Officers, directors & promoters (7)

More

• CIK 1914733 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search